Asbestos Mesothelioma Mesothelioma Treatment News About ELSS Top Mesothelioma Doctors

Dr. Valerie Rusch
New York, NY; Internationally recognized thoracic surgeon has led numerous research efforts to understand how patients respond to mesothelioma treatment...

Dr. David Jablons
San Francisco, CA; Chief of Thoracic Surgery at UCSF Medical Center specializing in pleural mesothelioma…

Enter your information to receive a comprehensive mesothelioma packet free of charge at your doorstep within 24 hours.

First Name:

Last Name:

Address:

City:

ST:

Zip:

Home Phone:

Work Phone:

Cell Phone:

Email Address:

Have you or someone you know been diagnosed with mesothelioma?

Yes   No

Mesothelioma Treatment | Articles & Abstracts

Therapy Studies

Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura - a single-institution experience with 189 patients.

PURPOSE: To determine the factors influencing the response to palliative radiotherapy 9RT) in malignant mesothelioma of the pleura (MM).

METHODS AND MATERIALS: A retrospective review was conducted of the records of all patients with mesothelioma who were referred to our institution between 1979 and 1996. A total of 227 RT series were administered to 189 patients with MM. Of these, 21 patients with chest wall nodules also received concomitant local hyperthermia.

RESULTS: The median survival was 5 months from the start of RT and only 17% of patients were alive at 1 year after treatment. Chest pain and painful chest wall metastases were the main indications for RT. A higher local response rate was seen for patients treated with a 4-Gy per fraction scheme, vs. those receiving fractions of less than 4 Gy (50% vs. 39%). Pain recurrence occurred predominantly within the previous RT field, and pain recurred after a median of 69 days (range 32-363) in the group treated using 4-Gy fractions. When compared with a matched group, patients treated with combined RT and hyperthermia had higher response rates and fewer in-field recurrences.

CONCLUSIONS: RT provides local palliation in at least 50% of patients with MM who were treated using a 4-Gy/fraction scheme to a media dose of 36 Gy. The low response rates with RT alone suggest that combined RT and local hyperthermia should be further evaluated in MM.

PMID: 10078630, UI: 99176516
Click here to order or save article

If you have any questions regarding treatment options or your legal rights, please contact us.